Differential topochemistry of three cationic amino acid transporter proteins, hCAT1, hCAT2 and hCAT3, in the adult human brain

Amino Acids

Volumn 44, Issue 2, 2013, Pages 423-433

  Jager K ^a   Wolf, S ^b   Dobrowolny, H ^b   Steiner, J ^b   Nave, H ^a   Maronde, E ^c   Bogerts, B ^b   Bernstein, H G ^b  

^a Institute of Anatomy and Cell Biology   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Distribution; hCAT1; hCAT2; hCAT3; Human brain; Immunohistochemistry

Indexed keywords

AMINO ACID TRANSPORTER; BRAIN PROTEIN; CATIONIC AMINO ACID TRANSPORTER 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTROCYTE; BASAL GANGLION; BRAIN CAPILLARY; BRAIN CORTEX; BRAIN NERVE CELL; CAUDATE NUCLEUS; CEREBELLUM; CHOROID PLEXUS; EPITHELIUM CELL; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PINEAL BODY; PONS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THALAMUS RETICULAR NUCLEUS; WHITE MATTER;

ADULT; ASTROCYTES; BRAIN; CATIONIC AMINO ACID TRANSPORTER 1; CATIONIC AMINO ACID TRANSPORTER 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OLIGODENDROGLIA; PROTEIN TRANSPORT;

RODENTIA;

EID: 84878375084     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1348-1     Document Type: Article

References (47)

1. Baker GB, Hallak JEC, Dilullo AF, Burback L, Dursun SM (2011) Amino acids in schizophrenia - glycine, serine and arginine. In: Ritsner MS (ed) Handbook of Schizophrenia spectrum disorders. Conceptual issues and neurobiological advances, vol 1. Springer, New York, pp 253-262
2. Baron M, Gomez-Tortosa E, Bochdanovits Z, Gobernado I, Rabano A, Munoz DG, Heutink P, Jimenez-Escrig A (2012) Extended kindred with recessive late-onset Alzheimer disease maps to locus 8p22-p21.2: a genome-wide linkage analysis. Alzheimer Dis Assoc Disord 26:91-95
3. Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, Falkai P, Bogerts B (1998) Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83:867-875
4. Bernstein HG, Baumann B, Danos P, Diekmann S, Bogerts B, Gundelfinger ED, Braunewell KH (1999) Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol 28:655-662
5. Bernstein HG, Krell D, Braunewell KH, Baumann B, Gundelfinger ED, Diekmann S, Danos P, Bogerts B (2001) Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia. J Neurocytol 30:661-670
6. Bernstein HG, Ernst T, Lendeckel U, Bukowska A, Ansorge S, Stauch R, Have ST, Steiner J, Dobrowolny H, Bogerts B (2009) Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia. J Psychiatr Res 43:1095-1105
7. Bernstein HG, Keilhoff G, Steiner J, Dobrowolny H, Bogerts B (2011a) Nitric Oxide and Schizophrenia: present knowledge and emerging concepts of therapy. CNS Neurol Disord: Drug Targets 10:792-807
8. Bernstein HG, Derst C, Stich C, Prüss H, Peters D, Krauss M, Bogerts B, Veh RW, Laube G (2011b) The agmatine-degrading enzyme agmatinase: a key to agmatine signaling in rat and human brain? Amino Acids 40:453-465
9. Bernstein HG, Stich C, Jäger K, Dobrowolny H, Wick M, Steiner J, Veh R, Bogerts B, Laube G (2012) Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders. Neuropharmacology 62:237-2346
10. Bielau H, Brisch R, Bernard-Mittelstaedt J, Dobrowolny H, Gos T, Baumann B, Mawrin C, Bernstein HG, Bogerts B, Steiner J (2012) Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder. Brain Res 1459:91-99
11. Braissant O, Gotoh T, Loup M, Mori M, Bachmann C (1999) l-Arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res 70:231-241
12. Braissant O, Gotoh T, Loup M, Mori M, Bachmann C (2001) Differential expression of the cationic amino acid transporter 2(B) in the adult rat brain. Brain Res Mol Brain Res 91:189-195
13. Closs EI (2002) Expression, regulation and function of carrier proteins for cationic amino acids. Curr Opin Nephrol Hypertens 11:99-107
14. Closs EI, Gräf P, Habermeier A, Cunningham JM, Förstermann U (1997) Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: three related carriers with distinct transport properties. Biochemistry 36:6462-6468
15. Closs EI, Boissel JP, Habermeier A, Rotmann A (2006) Structure and function of cationic amino acid transporters (CATs). J Membr Biol 213:67-77
16. Cui H, Lee JH, Kim JY, Koo BN, Lee JE (2012) The neuroprotective effect of agmatine after focal cerebral ischemia in diabetic rats. J Neurosurg Anesthesiol 24:39-50
17. Czapiga M, Colton CA (2003) Microglial function in human APOE3 and APOE4 transgenic mice: altered arginine transport. J Neuroimmunol 134:44-51
18. Egberongbe YI, Gentleman SM, Falkai P, Bogerts B, Polak JM, Roberts GW (1994) The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 59:561-578
19. Fiori LM, Turecki G (2008) Implication of the polyamine system in mental disorders. J Psychiatry Neurosci 33:102-110
20. Gensert JM, Ratan RR (2006) The metabolic coupling of arginine metabolism to nitric oxide generation by astrocytes. Antioxidants Redox Signaling 8:919-928
21. Harston GW, Sutherland BA, Kennedy J, Buchan AM (2010) The contribution of l-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity. J Cereb Blood Flow Metab 30:1804-1816
22. Holmans P, Weissman MM, Zubenko GS, Scheftner WA, Crowe RR, Depaulo JR Jr, Knowles JA, Zubenko WN, Murphy-Eberenz K, Marta DH, Boutelle S, McInnis MG, Adams P, Gladis M, Steele J, Miller EB, Potash JB, Mackinnon DF, Levinson DF (2007) Genetics of recurrent early-onset major depression (GenRED): final genome scan report. Am J Psychiatry 164:248-258
23. Hong KS, Won HH, Cho EY, Jeun HO, Cho SS, Lee YS, Park DY, Jang YL, Choi KS, Lee D, Kim MJ, Kim S, Han WS, Kim JW (2009) Genome-widely significant evidence of linkage of schizophrenia to chromosomes 2p24.3 and 6q27 in an SNP-based analysis of Korean families. Am J Med Genet B Neuropsychiatr Genet 150B:647-652
24. Hosokawa H, Sawamura T, Kobayashi S, Ninomiya H, Miwa S, Masaki T (1997) Cloning and characterization of a brain-specific cationic amino acid transporter. J Biol Chem 272:8717-8722
25. Hosokawa H, Ninomiya H, Sawamura T, Sugimoto Y, Ichikawa A, Fujiwara K, Masaki T (1999) Neuron-specific expression of cationic amino acid transporter 3 in the adult rat brain. Brain Res 838:158-165
26. Ito K, Groudine M (1997) A new member of the cationic amino acid transporter family is preferentially expressed in adult mouse brain. J Biol Chem 272:26780-26786
27. Jäger K, Paulsen F, Wohlrab J (2008) Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin. Histochem Cell Biol 129:321-329
28. Kakuda DK, MacLeod CL (1994) Na(+)-independent transport (uniport) of amino acids and glucose in mammalian cells. J Exp Biol 196:93-108
29. Kawahara K, Gotoh T, Oyadomari S, Kajizono M, Kuniyasu A, Ohsawa K, Imai Y, Kohsaka S, Nakayama H, Mori M (2001) Co-induction of argininosuccinate synthetase, cationic amino acid transporter-2, and nitric oxide synthase in activated murine microglial cells. Brain Res Mol Brain Res 90:165-173
30. Laube G, Bernstein HG (2012) Agmatine in the brain: an emerging "human" perspective. Neurosci Biobehav Rev 36:872
31. Malinski T (2007) Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis 11:207-218
32. Manner CK, Nicholson B, MacLeod CL (2003) CAT2 arginine transporter deficiency significantly reduces iNOS-mediated NO production in astrocytes. J Neurochem 85:476-482
33. Mohlake P, Whiteley CG (2010) Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides. Mol Neurobiol 41:149-158
34. Molderings GJ, Hänisch B (2012) Agmatine (decarboxylated l-arginine): physiological role and therapeutic potential. Pharmacol Ther 13:351-365
35. Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV, Yoon W, Kasperaviciūte D, Gennarelli M, Strittmatter WJ, Bonvicini C, Rossi G, Jayathilake K, Cola PA, McEvoy JP, Keefe RS, Fisher EM, St Jean PL, Giegling I, Hartmann AM, Möller HJ, Ruppert A, Fraser G, Crombie C, Middleton LT, St Clair D, Roses AD, Muglia P, Francks C, Rujescu D, Meltzer HY, Goldstein DB (2009) A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 5:e1000373
36. O'Kane RL, Viña JR, Simpson I, Zaragozá R, Mokashi A, Hawkins RA (2006) Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. Am J Physiol Endocrinol Metab 292:E412-E419
37. Oliveira RM, Guimarães FS, Deakin JF (2008) Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz J Med Biol Res 41:333-341
38. Perkins CP, Mar V, Shutter JR, Castillo J, Danilenko DM, Medlock ES, Ponting IL, Graham M, Stark KL, Zuo Y, Cunningham JM, Bosselman RA (1997) Anemia and perinatal death result from loss of the murine ecotropic retrovirusreceptor mCAT-1. Genes Dev 11:914-925
39. Scherer SW, Dawson G (2011) Risk factors for autism: translating genomic discoveries into diagnostics. Hum Genet 130:123-148
40. Schnorr O, Suschek CV, Kolb-Bachofen V (2003) The importance of cationic amino acid transporter expression in human skin. J Invest Dermatol 20:1016-1022
41. Stevens BR, Kakuda DK, Yu K, Waters M, Vo CB, Raizada MK (1996) Induced nitric oxide synthesis is dependent on induced alternatively spliced CAT-2 encoding l-arginine transport in brain astrocytes. J Biol Chem 271:24017-24022
42. Teerlink T (2005) ADMA metabolism and clearance. Vasc Med 10(Suppl 1):S73-S81
43. Uzbay TI (2012) The pharmacological importance of agmatine in the brain. Neurosci Biobehav Rev 36:502-519
44. Vékony N, Wolf S, Boissel JP, Gnauert K, Closs EI (2001) Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues. Biochemistry 40:12387-12394
45. White MF, Gazzola GC, Christensen HN (1982) Cationic amino acid transport into cultured animal cells. I. Influx into cultured human fibroblasts. J Biol Chem 257:4443-4449
46. Wiesinger H (2001) Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 64:365-391
47. Yu H, Iyer RK, Kern RM, Rodriguez WI, Grody WW, Cederbaum SD (2001) Expression of arginase isozymes in mouse brain. J Neurosci Res 66:406-422